Home > Insider Trading > Filing (0001652252-15-000012)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
12208	Bio Rad Laboratories Inc	BIO, BIOB	Laboratory Analytical Instruments (3826)	941381833

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
940805	D Norman Schwartz	C/O Bio-Rad Laboratories, Inc. 1000 Alfred Nobel Drive Hercules CA 94547	Chairman, President, And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Bio-Rad B Common Stock	Acquisiton	2015-09-08	2,400	$0.00	194,563	No	4	M	Direct
Bio-Rad B Common Stock	Disposition	2015-09-08	1,255	$0.00	193,308	No	4	J	Direct
Bio-Rad A Common Stock	Disposition	2015-09-09	1,255	$138.60	411,252	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	J	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Bio-Rad B Common Stock	Restricted Stock Units	Disposition	2015-09-08	2,400	$0.00	2,400	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Bio-Rad B Common Stock	12,486	Indirect	By Spouse
Bio-Rad B Common Stock	4,060,054	Indirect	By Blue Raven Partners, L.P.
Bio-Rad B Common Stock	13,726	Indirect	By DANSA Partnership

Footnotes

Shares of Class B common stock acquired on the vesting of restricted stock units.
The reporting person elected to convert shares of Class B common stock into Class A common stock on a 1-for-1 basis.
Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.
The reporting person disclaims beneficial ownership of these shares.
The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
The shares are held by a limited partnership of which the reporting person is a limited partner.
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.
The restricted stock units vest in five equal annual installments beginning September 8, 2011.